Review Paper: Recent developments in corona virus disease-2019 (Covid-19)

被引:0
作者
Vijayalakshmi, Shankar [1 ]
机构
[1] Vellore Inst Technol, CO2 Res & Green Technol Ctr, Vellore 14, Tamil Nadu, India
来源
RESEARCH JOURNAL OF BIOTECHNOLOGY | 2020年 / 15卷 / 11期
关键词
SARS-Co-V2; Epidemiology; Pathogenesis; Diagnosis; Modern treatments; Traditional treatments; SARS-CORONAVIRUS; FUNCTIONAL RECEPTOR; REPLICATION; PNEUMONIA; SPIKE; ACE2;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A respiratory illness by SARS-Co-V2 affected more than millions of people across the globe and killed thousands of people. This outbreak had believed to start in sea food market of Wuhan, China, during the sales of animals in the market and the virus had started spreading. The reservoir host for the virus is bats and from there it transferred to human through an intermediate host. The spread and transmission of the virus will be through direct contact of infected droplets or by inhalation which has a period of incubation about 2 to 14 days. The symptoms for the disease include cough, fever, sore throat, fatigue, difficulty in breathing, malaise and others. Most of the affected people will be asymptomatic, in adverse condition it may lead to acute respiratory distress syndrome, pneumonia and multiple organ dysfunction. Molecular methodology and CT scan are the usual diagnostic procedure. The ancestor of this virus is MERS-CoV and SARS-CoV. It is uncertain to determine the impact of this epidemic. Since there was no prominent treatment identified for treating the condition, it was spreading rapidly. The aim of this review is to give insights on epidemiology, virology, pathogenesis and available modern and traditional medicines for COVID-19.
引用
收藏
页码:159 / 169
页数:11
相关论文
共 55 条
  • [21] Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China
    He, JF
    Peng, GW
    Min, J
    Yu, DW
    Liang, WJ
    Zhang, SY
    Xu, RH
    Zheng, HY
    Wu, XW
    Xu, J
    Wang, ZH
    Fang, L
    Zhang, X
    Li, H
    Yan, XG
    Lu, JH
    Hu, ZH
    Huang, JC
    Wan, ZY
    Hou, JL
    Lin, JY
    Song, HD
    Wang, SY
    Zhou, XJ
    Zhang, GW
    Gu, BW
    Zheng, HJ
    Zhang, XL
    He, M
    Zheng, K
    Wang, BF
    Fu, G
    Wang, XN
    Chen, SJ
    Chen, Z
    Hao, P
    Tang, H
    Ren, SX
    Zhong, Y
    Guo, ZM
    Liu, Q
    Miao, YG
    Kong, XY
    He, WZ
    Li, YX
    Wu, CI
    Zhao, GP
    Chiu, RWK
    Chim, SSC
    Tong, YK
    [J]. SCIENCE, 2004, 303 (5664) : 1666 - 1669
  • [22] SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
    Hoffmann, Markus
    Kleine-Weber, Hannah
    Schroeder, Simon
    Krueger, Nadine
    Herrler, Tanja
    Erichsen, Sandra
    Schiergens, Tobias S.
    Herrler, Georg
    Wu, Nai-Huei
    Nitsche, Andreas
    Mueller, Marcel A.
    Drosten, Christian
    Poehlmann, Stefan
    [J]. CELL, 2020, 181 (02) : 271 - +
  • [23] Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China (vol 395, pg 497, 2020)
    Huang, C.
    Wang, Y.
    Li, X.
    [J]. LANCET, 2020, 395 (10223) : 496 - 496
  • [24] CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
    Jeffers, SA
    Tusell, SM
    Gillim-Ross, L
    Hemmila, EM
    Achenbach, JE
    Babcock, GJ
    Thomas, WD
    Thackray, LB
    Young, MD
    Mason, RJ
    Ambrosino, DM
    Wentworth, DE
    DeMartini, JC
    Holmes, KV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (44) : 15748 - 15753
  • [25] SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum
    Knoops, Kevin
    Kikkert, Marjolein
    van den Worm, Sjoerd H. E.
    Zevenhoven-Dobbe, Jessika C.
    van der Meer, Yvonne
    Koster, Abraham J.
    Mommaas, A. Mieke
    Snijder, Eric J.
    [J]. PLOS BIOLOGY, 2008, 6 (09): : 1957 - 1974
  • [26] Profile of specific antibodies to the SARS-associated coronavirus
    Li, G
    Chen, XJ
    Xu, AL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (05) : 508 - 509
  • [27] Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
    Li, WH
    Moore, MJ
    Vasilieva, N
    Sui, JH
    Wong, SK
    Berne, MA
    Somasundaran, M
    Sullivan, JL
    Luzuriaga, K
    Greenough, TC
    Choe, H
    Farzan, M
    [J]. NATURE, 2003, 426 (6965) : 450 - 454
  • [28] Lim J., 2020, J KOREAN MED SCI, V35, P71
  • [29] Liu J., OPEN LABEL MULTICENT
  • [30] Novel Immunodominant Peptide Presentation Strategy: a Featured HLA-A*2402-Restricted Cytotoxic T-Lymphocyte Epitope Stabilized by Intrachain Hydrogen Bonds from Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein
    Liu, Jun
    Wu, Peng
    Gao, Feng
    Qi, Jianxun
    Kawana-Tachikawa, Ai
    Xie, Jing
    Vavricka, Christopher J.
    Iwamoto, Aikichi
    Li, Taisheng
    Gao, George F.
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (22) : 11849 - 11857